MolNFT v1 · #38465 · protein
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of SARS-cov main protease
2GZ7: “Structure-based drug design and structural biology study of novel nonpeptide inhibitors of SARS-cov main…”. X-ray diffraction. MolNFT v1 #38465 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2GZ7
- Type
- protein
- Length
- 306 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P59641
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 306 | — | P59641 |
Compared structures
- 2GZ7 · Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P59641
- Elsewhere: RCSB PDB 2GZ7 · PDBe 2GZ7 · UniProt P59641
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.